ProCE Banner Activity

Educational Opportunities to Improve HER2 Testing and Use of Newer Therapies for HER2-Positive MBC Among Community Healthcare Professionals


This poster, presented at the 2022 San Antonio Breast Cancer Symposium (SABCS), illustrates challenges among oncology HCPs in optimally incorporating recommendations for the use of novel HER2-targeted therapies in the care of patients with HER2+ metastatic breast cancer.

Released: December 06, 2022

Expiration: December 05, 2023


Additional Information


Ryan P. Topping, PhD

Senior Scientific Director

Clinical Care Options

Telephone: 855.224.2241